Literature DB >> 23145420

Overactive bladder syndrome - management and treatment options.

Janine Arnold1, Nicholas McLeod, Ruban Thani-Gasalam, Prem Rashid.   

Abstract

BACKGROUND: Overactive bladder syndrome is a symptom-based clinical diagnosis. It is characterised by urinary urgency, frequency and nocturia, with or without urge urinary incontinence. These symptoms can often be managed in the primary care setting.
OBJECTIVE: This article provides a review on overactive bladder syndrome and provides advice on management for the general practitioner. DISCUSSION: Overactive bladder syndrome can have a significant effect on quality of life, and affects 12-17% of the population. Prevalence increases with age. The management of overactive bladder syndrome involves exclusion of underlying pathology. First line treatment includes lifestyle interventions, pelvic floor exercises, bladder training and antimuscarinic agents. Failure of conservative management necessitates urology referral. Second line therapies are more invasive, and include botulinum toxin, neuromodulation or surgical interventions such as augmentation cystoplasty or urinary diversion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23145420

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  15 in total

1.  Economic evaluation of sacral neuromodulation in overactive bladder: A Canadian perspective.

Authors:  Magdy M Hassouna; Hamid Sadri
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

2.  Women's perspective: intra-detrusor botox versus sacral neuromodulation for overactive bladder symptoms after unsuccessful anticholinergic treatment.

Authors:  Pooja Balchandra; Lynne Rogerson
Journal:  Int Urogynecol J       Date:  2014-03-15       Impact factor: 2.894

3.  CUA guideline: Diagnosis and treatment of interstitial cystitis/bladder pain syndrome.

Authors:  Ashley Cox; Nicole Golda; Genevieve Nadeau; J Curtis Nickel; Lesley Carr; Jacques Corcos; Joel Teichman
Journal:  Can Urol Assoc J       Date:  2016-05-12       Impact factor: 1.862

4.  Contribution of behavioral and cognitive therapy to managing overactive bladder syndrome in women in the absence of contributive urodynamic diagnosis.

Authors:  Brigitte G Marti; Françoise A Valentini; Gilberte Robain
Journal:  Int Urogynecol J       Date:  2014-11-07       Impact factor: 2.894

Review 5.  Research Findings on Overactive Bladder.

Authors:  Phani B Patra; Sayani Patra
Journal:  Curr Urol       Date:  2015-05-20

6.  Cost-effectiveness of mirabegron compared to tolterodine ER 4 mg for overactive bladder in Canada.

Authors:  Sender Herschorn; Jameel Nazir; Barbara Ramos; Zalmai Hakimi
Journal:  Can Urol Assoc J       Date:  2017 Mar-Apr       Impact factor: 1.862

7.  Short-term Effects of a Systematized Bladder Training Program for Idiopathic Overactive Bladder: A Prospective Study.

Authors:  Hahn-Ey Lee; Sung Yong Cho; Sangim Lee; Myong Kim; Seung-June Oh
Journal:  Int Neurourol J       Date:  2013-03-31       Impact factor: 2.835

8.  Antimuscarinic Medication Use in Elderly Patients with Overactive Bladder.

Authors:  Nandita Kachru; Sneha Sura; Satabdi Chatterjee; Rajender R Aparasu
Journal:  Drugs Aging       Date:  2016-10       Impact factor: 3.923

9.  PATTERN OF OVERACTIVE BLADDER IN SOUTHEAST NIGERIA.

Authors:  A C Odoemene
Journal:  J West Afr Coll Surg       Date:  2014 Jul-Sep

10.  Cholinergic Antagonists Combined with Electrical Stimulation or Bladder Training Treatments for Overactive Bladder in Female Adults: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Yang Cao; Jianwei Lv; Chen Zhao; Jiayi Li; Jing Leng
Journal:  Clin Drug Investig       Date:  2016-10       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.